Comparative compositional and functional analyses of Bothrops moojeni specimens reveal several individual variations.

Snake venoms are complex protein mixtures with different biological activities that can act in both their preys and human victims. Many of these proteins play a role in prey capture and in the digestive process of these animals.

It is known that some snakes are resistant to the toxicity of their own venom by mechanisms not yet fully elucidated. However, it was observed in the Laboratory of Herpetology of Instituto Butantan that some Bothrops moojeni individuals injured by the same snake species showed mortalities caused by envenoming effects. This study analyzed the biochemical composition of 13 venom and plasma samples from Bothrops moojeni specimens to assess differences in their protein composition.

Application of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) showed distinct venom protein profiles, but very homogeneous plasma profiles. Western Blotting (WB) was performed with plasma samples, which were submitted to incubation with the respective venom.

Some individuals showed an immunorecognized band zone around 25 kDa, indicating interaction between the same individual plasma and venom proteins. Crossed-WB assay using non-self-plasma and venom showed that this variability is due to venom protein composition instead of plasma composition.

These venoms presented higher caseinolytic, collagenolytic and coagulant activities than the venoms without these regions recognized by WB. Mass spectrometry analyses performed on two individuals revealed that these individuals present, in addition to higher protein concentrations, other exclusive proteins in their composition. When these same two samples were tested in vivo, the results also showed higher lethality in these venoms, but lower hemorrhagic activity than in the venoms without these regions recognized by WB.

5-FOA, 25g

EUR 963

Chlortetracycline HCl EP

C029-25G 25 g
EUR 141

25G Riboflavin

NAT1058 25G
EUR 80


NAT1498 25G
EUR 93


NAT1524 25G
EUR 152

25G AquaPor LE

NAT1020 25G
EUR 110

25G AquaPor ES

NAT1026 25G
EUR 127

25G AquaPor LM

NAT1030 25G
EUR 240

25G AquaPor HR

NAT1034 25G
EUR 197

25G DATD Ultrapure

NAT1044 25G
EUR 140

25G Ammonium Persulfate

NAT1062 25G
EUR 80

25G Alcian Blue

NAT1344 25G
EUR 162

25G Biebrich Scarlet

NAT1346 25G
EUR 120

25G Basic Fuchsin

NAT1350 25G
EUR 294

25G Methylene Blue

NAT1352 25G
EUR 156

25G Butyl PBD

NAT1510 25G
EUR 160

25G p-Terphenyl

NAT1520 25G
EUR 130

25G Bis-MSB

NAT1528 25G
EUR 187

25G AquaPor 3:1

NAT1038 25G
EUR 209

25G Fast Green FCF

NAT1348 25G
EUR 160

25G Amido Black 10B

NAT1354 25G
EUR 147

25G Xylene Cyanol FF

NAT1368 25G
EUR 193

AGAROSE 25G-125G -500G

A01-118-10kg 10 kg Ask for price

AGAROSE 25G-125G -500G

A01-118-2kg 2kg Ask for price

AGAROSE 25G-125G -500G

A01-118-500g 500 g
EUR 494

25G Bis (Methylene Bis-Acrylamide)

NAT1042 25G
EUR 84

DiagNano Albumin Silica Particles, 5 μm

DNG-C029 10 mL
EUR 647

DiagPoly Protein A Conjugated Polystyrene Particles, 3.0-3.9 µm

DNM-C029 5 mL
EUR 767

Chlortetracycline HCl EP

C029-100G 100 g
EUR 321

Chlortetracycline HCl EP

C029-5G 5 g
EUR 65

Recombinant Human Epidermal Growth Factor/EGF

C029-10ug 10ug
EUR 70
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-1mg 1mg
EUR 192
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-500ug 500ug
EUR 149
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-50ug 50ug
EUR 100
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Quinine Sulfate

Q012-25G 25g
EUR 64

Sarafloxacin Hydrochloride

S003-25G 25 g
EUR 168

Spectinomycin dihydrochloride pentahydrate

S006-25G 25 g
EUR 258

Streptomycin Sulfate

S008-25G 25 g
EUR 48


S012-25G 25 g
EUR 62

Sodium Pyruvate

S024-25G 25 g
EUR 63


S026-25G 25 g
EUR 58

Sulfadoxine (Sulphadoxine)

S035-25G 25 g
EUR 163

Streptomycin Sulfate EP

S040-25G 25 g
EUR 48


S060-25G 25g
EUR 138

Sulfapyridine USP

S065-25G 25 g
EUR 85


M079-25G 25 g
EUR 54

Menadione sodium bisulfite

M080-25G 25 g
EUR 64


M082-25G 25 g
EUR 76

N-Methylhydroxylamine hydrochloride

M088-25G 25 g
EUR 162

Neomycin Sulfate USP

N003-25G 25 g
EUR 72

Nalidixic Acid

N011-25G 25 g
EUR 77

Neomycin Sulfate EP

N012-25G 25 g
EUR 72


N013-25G 25 g
EUR 443

α-Naphthaleneacetic acid (1-NAA)

N024-25G 25 g
EUR 51

2-Naphthoxyacetic acid (BNOA)

N025-25G 25 g
EUR 49

Nisin Z

N055-25G 25 g
EUR 486

Oxolinic acid

O002-25G 25 g
EUR 335

Lactobionic acid

L017-25G 25 g
EUR 99


M011-25G 25 g
EUR 109

Paromomycin sulfate

P002-25G 25 g
EUR 499


P011-25G 25 g
EUR 161


P020-25G 25 g
EUR 84

Penicillin V potassium

P027-25G 25 g
EUR 86


P043-25G 25 g
EUR 345

110-Phenanthroline hydrochloride monohydrate

P067-25G 25 g
EUR 185

Putrescine Dihydrochloride

P103-25G 25 g
EUR 56


P128-25G 25g
EUR 83


O038-25G 25g
EUR 66


F004-25G 25 g
EUR 114

Fosfomycin Sodium

F013-25G 25 g
EUR 235

Folic acid USP

F014-25G 25 g
EUR 124


F036-25G 25 g
EUR 889

Flurbiprofen Sodium

F037-25G 25 g
EUR 889


F040-25G 25 g
EUR 215


H006-25G 25 g
EUR 65


H035-25G 25 g
EUR 250

Hexadecylpyridinium bromide

H036-25G 25 g
EUR 63

G418 Disulfate

G001-25G 25 g
EUR 322

Gentamicin Sulfate USP

G006-25G 25 g
EUR 392

Gentamicin Sulfate EP

G007-25G 25 g
EUR 399


G008-25G 25 g
EUR 173

G418 Disulfate (Low Endotoxin)

G048-25G 25 g
EUR 411


R003-25G 25 g
EUR 572


R009-25G 25 g
EUR 55

Irgasan (Triclosan)

I002-25G 25 g
EUR 118

Indole-3-acetic acid

I014-25G 25 g
EUR 87

Indole-3-butyric acid

I015-25G 25 g
EUR 123


I034-25G 25 g
EUR 199


I037-25G 25 g
EUR 115

Kanamycin Acid Sulfate BP

K004-25G 25 g
EUR 251

Kanamycin Sulfate USP

K008-25G 25 g
EUR 164

Kanamycin Acid Sulfate for BioProcessing

K012-25G 25 g
EUR 379

Kanamycin Acid Sulfate EW

K029-25G 25 g
EUR 248

Econazole nitrate

E001-25G 25 g
EUR 208


E002-25G 25 g
EUR 209

Erythromycin Ethylsuccinate

E004-25G 25 g
EUR 203

In conclusion, some Bothrops moojeni specimens differ in venom composition, which may have implications in envenomation. Moreover, the high individual venom variability found in this species demonstrates the importance to work with individual analyses in studies involving intraspecific venom variability and venom evolution.